Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 8Carcinoma, Non-Small-Cell Lung 8Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Ovarian Neoplasms 6Lung Neoplasms 6Head and Neck Neoplasms 5Carcinoma, Transitional Cell 4Stomach Neoplasms 3Lymphoma 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Glioblastoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Hepatocellular 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thymus Neoplasms 1Thymoma 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Microsatellite Instability 1

Interventions

pembrolizumab 2ribociclib 1napabucasin 1epacadostat 1amrubicin 1Sunitinib 1Plicamycin 1Paclitaxel 1Nivolumab 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Thymus Neoplasms × epacadostat × Clear all
NCT02364076 2019-12-13

Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma

Georgetown University

Phase 2 Unknown
45 enrolled 10 charts
Thoracic

Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡